HIGHLIGHTS
- What: The non-sunitinib TKIs were grouped together for analysis purposes. Most studies have shown a female preponderance of the disease; however, the study showed a slightly higher incidence in males . The study has several limitations: the retrospective nature of data collection, and the absence of brain imaging in asymptomatic patients at baseline to name a few. Despite these limitations, this study provides significant real-world data on the outcomes and toxicity profile of therapeutic options in ASPS in resource-limited settings.
- Who: Sanal Fernandes and collaborators from the ultra-rare sarcoma from tertiary care . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.